Background illustration for clinical trials search

Paid Clinical Trials Bellingham

Discover 208 paid clinical trials in Bellingham, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for
Sickle Cell Disease
Location: Vancouver, Tacoma WA, Calgary, Edmonton, Palo Alto CA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase 3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Vancouver, Seattle WA, Calgary, Sacramento CA, Lodi CA,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Vancouver, Seattle WA, Portland OR, Spokane WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Vancouver, Seattle WA, Portland OR, Calgary, Aurora CO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase 2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase 3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase 3, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Vancouver, Seattle WA, Tacoma WA, Portland OR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase 3, Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: Vancouver, Seattle WA, Salt Lake City UT, Orange CA,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase 3, Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

for
Latent Tuberculosis
Location: Vancouver, Seattle WA, Calgary, Edmonton, Denver CO,
Sponsor: Centers for Disease Control and Prevention

Sex: All

Age: 0+

Code: NCT03474029

Phase 2, Phase 3, Recruiting

Pancreatic Cancer Early Detection Consortium

for
Pancreas Cancer, Pancreas Cyst,
Location: Vancouver, Seattle WA, Portland OR, Sacramento CA,
Sponsor: Arbor Research Collaborative for Health

Sex: All

Age: 18 - 70+

Code: NCT04970056

Recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for
Rectal Cancer
Location: Vancouver, Seattle WA, Kirkland WA, Bellevue WA,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06205485

Phase 3, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Vancouver, Seattle WA, Calgary, Edmonton, Palo Alto CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase 1, Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Vancouver, Tacoma WA, Portland OR, Calgary, Edmonton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting